GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivoryon Therapeutics NV (FRA:05Y) » Definitions » Institutional Ownership

Vivoryon Therapeutics NV (FRA:05Y) Institutional Ownership : 9.86% (As of Jun. 06, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Vivoryon Therapeutics NV Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vivoryon Therapeutics NV's institutional ownership is 9.86%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vivoryon Therapeutics NV's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vivoryon Therapeutics NV's Float Percentage Of Total Shares Outstanding is 0.00%.


Vivoryon Therapeutics NV Institutional Ownership Historical Data

The historical data trend for Vivoryon Therapeutics NV's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivoryon Therapeutics NV Institutional Ownership Chart

Vivoryon Therapeutics NV Historical Data

The historical data trend for Vivoryon Therapeutics NV can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 16.23 16.36 15.97 15.89 15.39 15.64 15.39 9.86 9.86 9.86

Vivoryon Therapeutics NV Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Vivoryon Therapeutics NV (FRA:05Y) Business Description

Traded in Other Exchanges
Address
Weinbergweg 22, Halle, SN, DEU, 06120
Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.

Vivoryon Therapeutics NV (FRA:05Y) Headlines

No Headlines